Inhibitors of phosphodiesterase isoforms III or IV suppress islet-cell nitric oxide production

Laboratory Investigation

Volumn 81, Issue 8, 2001, Pages 1109-1117

  Beshay, Evette ^a   Prud'homme, Gérald J ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

8 BROMO CYCLIC AMP; BUCLADESINE; CILOSTAMIDE; CYCLOPHOSPHAMIDE; CYTOKINE; ISOPROTEIN; LIPOPOLYSACCHARIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PENTOXIFYLLINE; PHOSPHODIESTERASE; ROLIPRAM;

ANIMAL CELL; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETES MELLITUS; DNA CONTENT; ENZYME INHIBITION; INSULINOMA; MEMBRANE PERMEABILITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ANIMALS; CELLS, CULTURED; CULTURE TECHNIQUES; CYCLIC AMP; FEMALE; ISLETS OF LANGERHANS; MICE; MICE, INBRED NOD; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITORS; QUINOLONES; RNA, MESSENGER; ROLIPRAM; TUMOR CELLS, CULTURED;

EID: 0034889541     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780323     Document Type: Article

References (39)

1. Interleukin-1 beta-induced nitric oxide production from isolated rat islets is modulated by D-glucose and 3-isobutyl-l-methyl xanthine
2. Beneficial effects of phosphodiesterase inhibitors BRL 61063, pentoxicfylline, rolipram in murine models of endotoxic shock
3. Glucagon decreases cytokine induction of nitric oxide synthase and action on insulin secretion in RIN5F cells and rat and human islets of Langerhans
4. Cytotoxic action of IL-1β against pancreatic islets is mediated via nitric oxide formation and is inhibited by NG-monomethyl-L-arginine
5. The phosphodiesterase inhibitors pentoxifylline and rolipram suppress macrophage activation and nitric oxide production in vitro and in vivo
6. Therapeutic potential of phosphodiesterase inhibitors in Th1-mediated autoimmune diseases
7. Nitric oxide production by murine macrophage is inhibited by prolonged elevation of cAMP
8. Comparison of the effects of cilostazol and milrinone on intracellular cAMP levels and cellular functions in platelets and cardiac cells
9. Interleukin-1β-induced formation of EPR-detectable iron-nitrosyl complex in islets of Langerhans
10. Intraislet release of interleukin 1 inhibits β-cell function by inducing β-cell expression of inducible nitric oxide synthase
11. Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans
12. The harmony of the spheres: Inducible nitric oxide synthase and related genes in pancreatic beta cells
13. Reduced sensitivity of inducible nitric oxide synthasedeficient mice to multiple low-dose streptozotocin-induced diabetes
14. Nitric oxide synthase: Expression and expressional control of three isoforms
15. Pyrrolidine-dithiocarbamate inhibits NF-κβ mobilization and TNF production in human monocytes
16. Interferon-γ increases the sensitivity of the islets of Langerhans for inducible nitric oxide synthase expression induced by interleukin-1
17. Effect of pentoxifylline on nitric oxide released by murine macrophages
18. Preferential infiltration of macrophages during early stages of insulitis in diabetes-prone BB rats
19. The phosphodiesterase inhibitors pentoxifylline and rolipram prevent diabetes in NOD mice
20. Cytokines induce apoptosis in beta-cells isolated from mice lacking the inducible isoform of nitric oxide synthase (iNOS -/-)
21. Nitric oxide is a physiologic messenger
22. The role of interleukin-1 in the pathogenesis of IDDM
23. Modulation of inducible nitric oxide synthase in RIN m5F cells
24. Nitric oxide: Physiology, pathophysiology, and pharmacology
25. The physiology and pathophysiology of nitric oxide/superoxide system
26. Stimulation of the nitric oxide synthase pathway in human hepatocyte by cytokines and endotoxine
27. Increased cAMP attenuates induction of inducible nitric oxide synthase in rat primary astrocytes
28. Cyclic AMP phosphodiesterase of human and rat islets of Langerhans: Contributions of type III and IV to the modulation of insulin secretion
29. Prevention of autoimmune diabetes by intramuscular gene therapy with a nonviral vector encoding an interferon-gamma/lgG1 fusion protein
30. Cytokines and their roles in pancreatic islet β-cell destruction and insulindependent diabetes mellitus
31. DNA fluorometric assay in 96 well tissue culture plates using Hoechst 33258 after cell lysis by freezing in distilled water
32. Phosphodiesterase inhibitor pentoxifylline, a selective suppressor of T helper type 1- but not type 2-associated lymphokine production, prevents induction of experimental autoimmune encephalomyelitis in Lewis rats
33. PDE isozymes as targets for anti-asthma drugs
34. Pentoxifylline suppresses irritant and contact hypersensitivity reaction
35. Genetic and pathogenic basis of autoimmune diabetes in NOD mice
36. The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis
37. Inhibition of insulin secretion by interleukin-1 β and tumour necrosis factor-α via an L-arginine dependent nitric oxide generation mechanism
38. Effect of exogenous and endogenous nitric oxide on mitochondrial respiration of rat hepatocytes
39. Cell specific effects of pentoxifylline on nitric oxide production and inducible nitric oxide synthase mRNA expression